Pharmagreen Biotech (Pharmagreen Biotech) Days Inventory : 0.00 (As of Jun. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Pharmagreen Biotech's Average Total Inventories for the three months ended in Jun. 2023 was $0.01 Mil. Pharmagreen Biotech's Cost of Goods Sold for the three months ended in Jun. 2023 was $0.00 Mil.

The historical rank and industry rank for Pharmagreen Biotech's Days Inventory or its related term are showing as below:

PHBI' s Days Inventory Range Over the Past 10 Years
Min: 0 Med: 0 Max: 3467.5
Current: 3467.5

During the past 7 years, Pharmagreen Biotech's highest Days Inventory was 3467.50. The lowest was 0.00. And the median was 0.00.

PHBI's Days Inventory is ranked worse than
99.38% of 970 companies
in the Drug Manufacturers industry
Industry Median: 158.365 vs PHBI: 3467.50

Pharmagreen Biotech's Days Inventory stayed the same from Jun. 2022 (0.00) to Jun. 2023 (0.00).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Pharmagreen Biotech's Inventory Turnover for the three months ended in Jun. 2023 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pharmagreen Biotech's Inventory-to-Revenue for the three months ended in Jun. 2023 was 9.50.

Pharmagreen Biotech Days Inventory Historical Data

The historical data trend for Pharmagreen Biotech's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Days Inventory Chart

Pharmagreen Biotech Annual Data

Trend

Apr08

Apr09

Sep18

Sep19

Sep20

Sep21

Sep22

Days Inventory

Get a 7-Day Free Trial

Pharmagreen Biotech Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Days Inventory	Get a 7-Day Free Trial															-	-	-	912.50	-

Competitive Comparison of Pharmagreen Biotech's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagreen Biotech's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Days Inventory distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's Days Inventory falls into.

Pharmagreen Biotech Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pharmagreen Biotech's Days Inventory for the fiscal year that ended in Sep. 2022 is calculated as

	Days Inventory (A: Sep. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Sep. 2021 )	+	Total Inventories (A: Sep. 2022 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2022 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Pharmagreen Biotech's Days Inventory for the quarter that ended in Jun. 2023 is calculated as:

	Days Inventory (Q: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Mar. 2023 )	+	Total Inventories (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (0.01	+	0.009)	/	2 )	/	0	*	365 / 4
=	0.0095					/	0	*	365 / 4
=	N/A

Pharmagreen Biotech (OTCPK:PHBI) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Pharmagreen Biotech's Inventory Turnover for the three months ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0.0095
	=	0.00

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pharmagreen Biotech's Inventory to Revenue for the three months ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.0095	/	0.001
	=	9.50

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Pharmagreen Biotech Days Inventory Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

112 North Curry Street, Carson, NV, USA, 89703

Website

https://www.pharmagreen.ca

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.